Matches in SemOpenAlex for { <https://semopenalex.org/work/W4253206475> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W4253206475 endingPage "186" @default.
- W4253206475 startingPage "179" @default.
- W4253206475 abstract "This retrospective study in 61 cats with malignant lymphomas examined the efficacy of a well-established chemotherapy protocol (cyclophosphamide, vincristine, and prednisolone [COP]) in the Netherlands, a country with a low prevalence of feline leukemia virus (FeLV). Twenty-two cats (36.1%) had mediastinal lymphoma, 11 (18.0%) had alimentary lymphoma, 7 (11.5%) had peripheral lymphoma, 8 (13.1%) had nasal lymphoma, and 13 (21.3%) had miscellaneous lymphoma (including renal lymphoma in 2 [3.3%]). Of the 54 cats that were tested, only 4 (7.4%) were FeLV positive. Complete remission (CR) was achieved in 46 of the 61 cats (75.4%). The estimated 1- and 2-year disease-free periods (DFPs) in the 46 cats with CR were 51.4 and 37.8%, respectively, whereas the median duration of remission was 251 days. The overall estimated 1-year survival rate in all cats was 48.7%, and the 2-year survival rate was 39.9%, with a median survival of 266 days. The median survival time and the 1-year survival rate for mediastinal lymphoma were 262 days and 49.4%, respectively. Siamese cats had a more favorable prognosis for survival and remission than other breeds. Response to therapy in this study was shown to be a significant prognostic indicator. CR is necessary for long-term survival. Cats that did not achieve CR had little chance of survival for longer than 1 year. Young Siamese cats in this study had a greater tendency to develop mediastinal malignant lymphoma at a young age, and all were FeLV negative. In comparison with results reported in other studies with different combination chemotherapy protocols, these are among the highest percentages of remission and the longest survival rates for cats with malignant lymphoma." @default.
- W4253206475 created "2022-05-12" @default.
- W4253206475 creator A5024241223 @default.
- W4253206475 creator A5042296453 @default.
- W4253206475 creator A5046890902 @default.
- W4253206475 creator A5077794028 @default.
- W4253206475 date "2002-03-01" @default.
- W4253206475 modified "2023-10-09" @default.
- W4253206475 title "Chemotherapy with Cyclophosphamide, Vincristine, and Prednisolone (COP) in Cats with Malignant Lymphoma: New Results with an Old Protocol" @default.
- W4253206475 cites W1822326068 @default.
- W4253206475 cites W1990097826 @default.
- W4253206475 cites W1997398776 @default.
- W4253206475 cites W2014721790 @default.
- W4253206475 cites W2020816772 @default.
- W4253206475 cites W2045440265 @default.
- W4253206475 cites W2119238930 @default.
- W4253206475 cites W2131342233 @default.
- W4253206475 cites W2131759576 @default.
- W4253206475 cites W2164817077 @default.
- W4253206475 doi "https://doi.org/10.1111/j.1939-1676.2002.tb02352.x" @default.
- W4253206475 hasPublicationYear "2002" @default.
- W4253206475 type Work @default.
- W4253206475 citedByCount "108" @default.
- W4253206475 countsByYear W42532064752012 @default.
- W4253206475 countsByYear W42532064752013 @default.
- W4253206475 countsByYear W42532064752014 @default.
- W4253206475 countsByYear W42532064752015 @default.
- W4253206475 countsByYear W42532064752016 @default.
- W4253206475 countsByYear W42532064752017 @default.
- W4253206475 countsByYear W42532064752018 @default.
- W4253206475 countsByYear W42532064752019 @default.
- W4253206475 countsByYear W42532064752020 @default.
- W4253206475 countsByYear W42532064752021 @default.
- W4253206475 countsByYear W42532064752022 @default.
- W4253206475 countsByYear W42532064752023 @default.
- W4253206475 crossrefType "journal-article" @default.
- W4253206475 hasAuthorship W4253206475A5024241223 @default.
- W4253206475 hasAuthorship W4253206475A5042296453 @default.
- W4253206475 hasAuthorship W4253206475A5046890902 @default.
- W4253206475 hasAuthorship W4253206475A5077794028 @default.
- W4253206475 hasBestOaLocation W42532064751 @default.
- W4253206475 hasConcept C126322002 @default.
- W4253206475 hasConcept C141071460 @default.
- W4253206475 hasConcept C203014093 @default.
- W4253206475 hasConcept C2776090121 @default.
- W4253206475 hasConcept C2776283816 @default.
- W4253206475 hasConcept C2776694085 @default.
- W4253206475 hasConcept C2776715498 @default.
- W4253206475 hasConcept C2776755627 @default.
- W4253206475 hasConcept C2777478502 @default.
- W4253206475 hasConcept C2779338263 @default.
- W4253206475 hasConcept C2779429289 @default.
- W4253206475 hasConcept C2779904517 @default.
- W4253206475 hasConcept C71924100 @default.
- W4253206475 hasConcept C8891405 @default.
- W4253206475 hasConcept C90924648 @default.
- W4253206475 hasConceptScore W4253206475C126322002 @default.
- W4253206475 hasConceptScore W4253206475C141071460 @default.
- W4253206475 hasConceptScore W4253206475C203014093 @default.
- W4253206475 hasConceptScore W4253206475C2776090121 @default.
- W4253206475 hasConceptScore W4253206475C2776283816 @default.
- W4253206475 hasConceptScore W4253206475C2776694085 @default.
- W4253206475 hasConceptScore W4253206475C2776715498 @default.
- W4253206475 hasConceptScore W4253206475C2776755627 @default.
- W4253206475 hasConceptScore W4253206475C2777478502 @default.
- W4253206475 hasConceptScore W4253206475C2779338263 @default.
- W4253206475 hasConceptScore W4253206475C2779429289 @default.
- W4253206475 hasConceptScore W4253206475C2779904517 @default.
- W4253206475 hasConceptScore W4253206475C71924100 @default.
- W4253206475 hasConceptScore W4253206475C8891405 @default.
- W4253206475 hasConceptScore W4253206475C90924648 @default.
- W4253206475 hasIssue "2" @default.
- W4253206475 hasLocation W42532064751 @default.
- W4253206475 hasOpenAccess W4253206475 @default.
- W4253206475 hasPrimaryLocation W42532064751 @default.
- W4253206475 hasRelatedWork W1984792832 @default.
- W4253206475 hasRelatedWork W1989169764 @default.
- W4253206475 hasRelatedWork W1999202698 @default.
- W4253206475 hasRelatedWork W2051017580 @default.
- W4253206475 hasRelatedWork W2079621758 @default.
- W4253206475 hasRelatedWork W2080555893 @default.
- W4253206475 hasRelatedWork W2083267636 @default.
- W4253206475 hasRelatedWork W2396609006 @default.
- W4253206475 hasRelatedWork W2409175605 @default.
- W4253206475 hasRelatedWork W2412912370 @default.
- W4253206475 hasVolume "16" @default.
- W4253206475 isParatext "false" @default.
- W4253206475 isRetracted "false" @default.
- W4253206475 workType "article" @default.